GlassScriptPhysician profile
Amanda Knauer Hale
NPI 1235432519
$13,027.71
in general payments reported to CMS, 2019-2025
72 companies · $2,369 in 2025
The $2,369 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,911 · 2022: $2,574 · 2023: $3,679 · 2024: $2,494 · 2025: $2,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,375 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,374.70 |
| Education | $167.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $831.89 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $753.67 | 2021-2025 | Keytruda, Lynparza |
| Pfizer INC. | $658.42 | 2021-2025 | |
| Daiichi Sankyo INC. | $634.94 | 2021-2025 | Injectafer, Enhertu, Datroway |
| Astrazeneca Pharmaceuticals LP | $568.66 | 2021-2025 | Calquence, Lynparza, Imfinzi |
| Takeda Pharmaceuticals U.S.A., INC. | $485.40 | 2021-2025 | Ninlaro, Alunbrig, Fruzaqla |
| Janssen Biotech, INC. | $472.22 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Abbvie INC. | $465.15 | 2021-2024 | |
| Genzyme Corporation | $447.64 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $442.12 | 2021-2025 | Libtayo |
| Seagen INC. | $435.56 | 2021-2023 | Padcev, Tukysa, Adcetris |
| Amgen INC. | $418.57 | 2021-2023 | Kyprolis, Blincyto, Lumakras |
| Exelixis INC. | $345.86 | 2021-2025 | Cabometyx |
| Incyte Corporation | $336.79 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Bayer Healthcare Pharmaceuticals INC. | $321.20 | 2021-2025 |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $306.79 | 2021-2025 | Reblozyl, Pomalyst, Opdualag |
| Pharmacyclics LLC, An Abbvie Company | $297.37 | 2021-2023 | Imbruvica |
| Astellas Pharma US INC | $280.85 | 2021-2025 | Padcev, Xtandi, Vyloy |
| Myriad Genetic Laboratories, INC. | $265.85 | 2023-2024 | Precisetumor, Myrisk |
| Jazz Pharmaceuticals INC. | $253.91 | 2021-2025 | |
| Stemline Therapeutics INC. | $251.18 | 2023-2025 | Orserdu, Elzonris |
| Gilead Sciences, INC. | $250.36 | 2022-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $231.58 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Coherus Oncology, INC. | $182.50 | 2021-2025 | Loqtorzi, Udenyca |
| Eisai INC. | $179.09 | 2021-2025 | |
| Aveo Pharmaceuticals, INC. | $174.09 | 2022-2025 | Fotivda |
| Lilly USA, LLC | $163.89 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Karyopharm Therapeutics INC. | $155.58 | 2022-2024 | Xpovio |
| Blueprint Medicines Corporation | $155.07 | 2021-2025 | Ayvakit |
| Adaptive Biotechnologies Corporation | $138.32 | 2023-2025 | Clonoseq |
| Alexion Pharmaceuticals, INC. | $123.85 | 2021-2024 | Ultomiris |
| Servier Pharmaceuticals LLC | $119.50 | 2022-2025 | |
| Puma Biotechnology, INC. | $118.30 | 2023-2025 | Nerlynx |
| Mirati Therapeutics, INC. | $110.50 | 2023-2024 | Krazati |
| Genentech USA, INC. | $109.28 | 2021-2025 | Alecensa, Tecentriq, Phesgo |
| Ipsen Biopharmaceuticals, INC | $105.92 | 2021-2025 | Onivyde, Tazverik |
| Sobi, INC | $99.72 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $96.21 | 2022-2023 | Opdivo |
| Beigene USA, INC. | $91.89 | 2021-2024 | Brukinsa |
| Adc Therapeutics America, INC. | $76.53 | 2022-2025 | |
| Beone Medicines USA, INC. | $67.69 | 2025 | Brukinsa |
| Array Biopharma INC | $61.52 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.21 | 2023-2024 | Gilotrif |
| Tersera Therapeutics LLC | $53.01 | 2023-2025 | Xermelo, Quzyttir |
| Morphosys, US INC. | $48.98 | 2021-2024 | Monjuvi |
| Geron Corporation | $46.30 | 2025 | Rytelo |
| Agios Pharmaceuticals, INC. | $45.35 | 2024-2025 | Pyrukynd |
| Pharmacosmos Therapeutics INC. | $43.09 | 2024 | Cosela |
| G1 Therapeutics, INC. | $41.85 | 2023 | Cosela |
| Emmaus Medical, INC. | $40.11 | 2021-2023 | Endari |
| Cti Biopharma Corp. | $39.32 | 2023 | Vonjo |
| Pharmaessentia USA Corporation | $38.45 | 2025 | Besremi |
| Epizyme, INC. | $36.20 | 2021-2022 | |
| Atricure, INC. | $35.03 | 2024 | |
| Legend Biotech USA INC. | $33.05 | 2025 | Carvykti |
| Iovance Biotherapeutics, INC. | $32.49 | 2025 | Amtagvi |
| Acrotech Biopharma INC. | $30.69 | 2022-2025 | Beleodaq |
| Sun Pharmaceutical Industries INC. | $29.54 | 2022 | |
| Springworks Therapeutics, INC. | $28.67 | 2025 | Gomekli |
| Organon LLC | $28.08 | 2023 | Ontruzant |
| Deciphera Pharmaceuticals INC. | $26.49 | 2023 | Qinlock |
| Syndax Pharmaceuticals, INC. | $24.99 | 2025 | |
| Acceleron Pharma, INC. | $24.03 | 2021 | |
| Caris Mpi, INC. | $22.40 | 2025 | Mi Cancer Seek |
| Taiho Oncology, INC. | $21.07 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.46 | 2025 | Erleada |
| Fresenius Kabi USA, LLC | $19.39 | 2025 | Stimufend |
| Foundation Medicine, INC. | $18.62 | 2022 | |
| Mylan Institutional INC. | $18.11 | 2021 | |
| Rigel Pharmaceuticals, INC. | $17.77 | 2025 | Gavreto, Tavalisse, Rezlidhia |
| Dova Pharmaceuticals | $13.64 | 2021 | |
| Global Blood Therapeutics, INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
Keytruda $449Venclexta $331Libtayo $324Kisqali $322Tukysa $272Ibrance $260Orserdu $225Precisetumor $224Padcev $216Ninlaro $210Imbruvica $192Lynparza $191Calquence $168Xtandi $167Zepzelca $159Tecvayli $159Injectafer $155Darzalex $154Fotivda $144Piqray $140Clonoseq $138Sarclisa $134Xpovio $127Talvey $120Trodelvy $119Lenvima $116Ayvakit $115Jaypirca $115Verzenio $115Krazati $111Enhertu $104Jakafi $103Adcetris $100Cabometyx $97.57Nubeqa $94.45Vitrakvi $93.78Stivarga $93.78Elrexfio $93.13Brukinsa $91.14Vonjo $87.28Udenyca $85.41Cosela $84.94Epkinly $77.08Alunbrig $77.05Mektovi $72.11Braftovi $72.11Fruzaqla $71.87Erleada $69.78Tibsovo $68.21Inlyta $67.75Wayrilz $64.61Kyprolis $63.75Reblozyl $63.38Bosulif $62.84Pomalyst $59.96Opdualag $59.06Datroway $58.76Retevmo $58.48Onivyde $57.65Gilotrif $53.21Talzenna $52.53Orgovyx $52.53Doptelet $51.76Ojjaara $49.47Jemperli $49.17Zejula $49.17Ultomiris $48.15Oxbryta $48.08Blincyto $47.46Opdivo $47.02Rytelo $46.30Myrisk $42.10Besremi $38.45Monjuvi $37.42Imfinzi $36.66Besponsa $36.65Nerlynx $35.07Synergy Ablation System $35.03Scemblix $34.43Carvykti $33.05Amtagvi $32.49Tecentriq $32.44Alecensa $32.44Bavencio $32.20Loqtorzi $32.02Phesgo $31.95Tazverik $30.36Xermelo $30.26Elitek $30.17Lumakras $30.11Gomekli $28.67Pyrukynd $28.57Endari $28.29Ontruzant $28.08Lorbrena $27.62Fabhalta $27.35Comirnaty $27.16Qinlock $26.49Elzonris $25.89Iclusig $25.00
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.